Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Formulary Design Experts

Council Members in this Study Group: 252

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Samir Mehta, MD

Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of PennsylvaniaHealth...

1 recent event(s)
Avram Goldberg, MD,FACR, Assistant Professor , Albert Einstein College of MedicineAvram Goldberg, MD,FACR

Assistant Professor
Albert Einstein College of Medicine
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Avram Goldberg, MD, FACR, is Attending Physician at North Shore University Hospital and Assistant Professor at the Albert Einstein College of Medicine, New York. He is part of the Division of Rheumatology where he is responsible for treatment of autoimmune and musculoskeletal diseases including rheumatoid...

Carrie Harris-Muller, MBA, MHA

Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Carrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive leadership positions in healthcare, including Cigna...

Alexander Bailey, MD

Associate Spine Surgeon
Heartland Hand and Spine Orthopedic Center
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Alexander Bailey, MD, is Medical Director of Heartland Spine & Specialty Hospital and a board certified Associate Spine Surgeon at the Heartland Hand & Spine Orthopedic Center in Kansas. Dr. Bailey practices at three area hospitals including a privately owned specialty hospital. He specializes in adult...

Leo Pavliv, RPh, MBA

VP Operations
CUMBERLAND PHARMACEUTICALS, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Leo Pavliv, RPh, MBA, is Vice President Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical and non-clinical development, manufacturing, and quality...

Vikram Singh, MBA

Director in Health and Productivity Practice
Buck Consultants, LLC. (Mellon Consultants)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Vikram Singh, MBA, is the Director in the Health and Productivity Practice at Buck Consultants. His expertise is in the financial and business aspects of pharmacy benefit management. Mr. Singh provides strategic advice in the areas of pharmacy benefit and health care finance, and on mergers and acquisitions...

Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM

Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Dea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...

4 recent news post(s)
2 recent event(s)
Steven Miller, MS, DPH, President, Steven Miller, MS, DPHSteven Miller, MS, DPH

President
Steven Miller, MS, DPH
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Steven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement issues, where he is working since February...

1 recent news post(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Clarification of Benefits , Allow Cost Comparisions and Speed Claims Payments

September 23, 2009

GLG Expert Contributor

Deficit Plays into Health Reform | www.washingtonpost.com

Health insurance coverage should be defined by specific ICD-9 codes with associated numbers of CPT-4 (service) codes allowed for each diagnosis. This structure would permit : benefit and cost comparisions between insurers, allow patients to understand which health problems are covered, and the number...

Sex - we can chemically get it up and now last longer?

August 2, 2009

GLG Expert Contributor

Sciele Pharma And Plethora Solutions Announce Positive Results Of Final Phase III Pivotal Trial For PSD502 For Premature Ejaculation | www.medicalnewstoday.com

?? breakthrough

A missed opportunity - or is it?

June 30, 2009

GLG Expert Contributor

FDA throws up roadblock for Takeda's diabetes drug | www.fiercebiotech.com

Plusses and minuses of not getting in the market now.

Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone

April 13, 2009

Aemad Aslam, MBA, President, MindPharma

Sun Pharma gets USFDA's nod to market painkillers | www.hindu.com

Sun Pharma can greatly benefit from the nationwide shortage of Oxycodone Immediate Release Tablet, by getting approval from the FDA on their own generic. With recent recalls from different manufacturers, and the shortage of a comparable product Morphine Sulphate, the FDA currently estimates that return...

Denosumab May Help to Salvage Bone Health in Metastatic Disease

April 13, 2009

GLG Expert Contributor

Randomized Phase II Trial Of Denosumab In Patients With Bone Metastases From Prostate Cancer, Or Other Neoplasms After Intravenous Bisphosphonates | www.medicalnewstoday.com

Metastatic spread to the bone is a common and problematic complication for many patients with advanced cancer.  Current treatment with bisphosphonates only modestly controls skeletal spread. This study suggests that the monoclonal antibody Denosumab has biologic and clinical activity to help patients...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Managed Care Health Insurer, For-Profit
  • Facility, Academic Medical Center
  • Managed Care Health Insurer, Non-Profit
  • Facility, Non-Academic/Community Hospital
  • Consultancy, Healthcare-Focused
  • Non-Academic Community Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Blue Cross/Blue Shield Non-Profit Health Insurer
  • Pharmaceutical Benefits Manager, Small <10 M Lives
  • Consultancy, Pharma-Focused
  • Facility, Government/Public Hospital
  • Pharmaceutical Benefits Manager, Large >10 M Lives
  • Pharmaceuticals Manufacturer

Members in this Study Group often have these job titles:

  • Pharmacist - RPh/PharmD
  • Director
  • Physician - Attending Physician
  • President
  • Medical Director
  • Manager
  • Physician - Director

Related Study Groups

Study Group Name No. Members
Pharmacists (US) 2079
Generic Drug Economic Experts 767
Economic Experts on Managed Care 716
Managed Care Experts 670
Medicare Experts 495
Pharmacists at Hospitals 634
Economic Experts on Formulary Designs (US) 51

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Formulary Design Experts Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Formulary Design Experts have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare